Log in to save to my catalogue

CNP-miR146a Decreases Inflammation in Murine Acute Infectious Lung Injury

CNP-miR146a Decreases Inflammation in Murine Acute Infectious Lung Injury

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5285ce1c028043fe9eb4c1243b38279c

CNP-miR146a Decreases Inflammation in Murine Acute Infectious Lung Injury

About this item

Full title

CNP-miR146a Decreases Inflammation in Murine Acute Infectious Lung Injury

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2023-08, Vol.15 (9), p.2210

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Acute respiratory distress syndrome (ARDS) has approximately 40% in-hospital mortality, and treatment is limited to supportive care. Pneumonia is the underlying etiology in many cases with unrestrained inflammation central to the pathophysiology. We have previously shown that CNP-miR146a, a radical scavenging cerium oxide nanoparticle (CNP) conjuga...

Alternative Titles

Full title

CNP-miR146a Decreases Inflammation in Murine Acute Infectious Lung Injury

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5285ce1c028043fe9eb4c1243b38279c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5285ce1c028043fe9eb4c1243b38279c

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics15092210

How to access this item